DJIA 17,966.50 -71.47 -0.40%
NASDAQ 5,037.94 -22.30 -0.44%
S&P 500 2,105.12 -3.80 -0.18%
market minute promo

AbbVie Inc. (NYSE: ABBV)

65.41 0.39 (0.59%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABBV $65.41 0.59%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $64.60
Previous Close $65.02
Daily Range $64.20 - $65.45
52-Week Range $49.50 - $70.76
Market Cap $104.2B
P/E Ratio 48.89
Dividend (Yield) $2.04 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,005,184
Average Daily Volume 11,791,519
Current FY EPS $4.20



AbbVie Inc. (ABBV) Description

AbbVie Inc. Website:

News & Commentary

Can You Guess Which State Won't Pay for Hepatitis C Drugs?

One state decided to take a hard line stance against Gilead's pricey hep C drugs last year. And this decision may end up turning into a huge windfall for AbbVie's rival therapy. Here's why.

All You Need To Know About HCV From The EASL Conference This Weekend

Will Express Scripts (ESRX) Disappoint Earnings in Q1? - Analyst Blog

Learning From The Masters: Q&A Session With Buyandhold 2012

3 'Safe' Biotech Picks

I Called It: What's The Take Home Message?

Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs

Astra Deals Add To Ballooning Up-Front Payments

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog

See More ABBV News...